VAN DE PLAS PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
VAN DE PLAS PHARMA
Largest movements
- Receivables within one year +€47,350
up €47,350 (+45.4%), from €104,323 to €151,673
of which Other amounts receivable: +€38,194
- Tangible fixed assets -€26,660
down €26,660 (-10.3%), from €259,369 to €232,708
- Cash -€25,939
down €25,939 (-43.3%), from €59,965 to €34,026
mainly Receivables within one year (-€47,350) and Net result for the year (-€26,266)
- Stocks and contracts +€6,730
up €6,730 (+4.9%), from €136,231 to €142,961
- Trade debts +€65,780
up €65,780 (+77.2%), from €85,248 to €151,028
- Profit (loss) carried forward -€26,266
new in 2025: -€26,266
- Debts after one year -€19,513
down €19,513 (-9.3%), from €209,792 to €190,279
- Other debts -€17,645
down €17,645 (-19.5%), from €90,519 to €72,874
- Short-term financial debts -€17,300
down €17,300 (-100%), from €17,300 to €0
- Gross operating margin -€58,901
down €58,901 (-54.2%), from €108,710 to €49,809
- Staff costs +€30,644
up €30,644 (+409%), from €7,498 to €38,142
- Taxes -€2,855
down €2,855 (-100%), from €2,855 to €0
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €561,766 | €566,351 | +€4,585 | +0.8% |
| Fixed assets | 21/28 | €259,369 | €232,708 | -€26,660 | -10.3% |
| Tangible fixed assets | 22/27 | €259,369 | €232,708 | -€26,660 | -10.3% |
| Land and buildings | 22 | €168,496 | €156,364 | -€12,133 | -7.2% |
| Plant, machinery and equipment | 23 | €31,973 | €25,963 | -€6,010 | -18.8% |
| Furniture and vehicles | 24 | €4 | €0 | -€4 | -100% |
| Other tangible fixed assets | 26 | €58,895 | €50,381 | -€8,514 | -14.5% |
| Current assets | 29/58 | €302,397 | €333,643 | +€31,246 | +10.3% |
| Stocks and contracts in progress | 3 | €136,231 | €142,961 | +€6,730 | +4.9% |
| Stocks | 30/36 | €136,231 | €142,961 | +€6,730 | +4.9% |
| Amounts receivable within one year | 40/41 | €104,323 | €151,673 | +€47,350 | +45.4% |
| Trade receivables | 40 | €93,387 | €102,544 | +€9,157 | +9.8% |
| Other amounts receivable | 41 | €10,935 | €49,129 | +€38,194 | +349% |
| Cash at bank and in hand | 54/58 | €59,965 | €34,026 | -€25,939 | -43.3% |
| Deferred charges and accrued income | 490/1 | €1,879 | €4,983 | +€3,104 | +165% |
| Total equity and liabilities | 10/49 | €561,766 | €566,351 | +€4,585 | +0.8% |
| Equity | 10/15 | €136,914 | €110,648 | -€26,266 | -19.2% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €118,322 | €118,322 | = | 0.0% |
| Distributable reserves | 133 | €118,322 | €118,322 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | -€26,266 | -€26,266 | |
| Amounts payable | 17/49 | €424,852 | €455,703 | +€30,851 | +7.3% |
| Amounts payable after more than one year | 17 | €209,792 | €190,279 | -€19,513 | -9.3% |
| Financial debts | 170/4 | €209,792 | €190,279 | -€19,513 | -9.3% |
| Amounts payable within one year | 42/48 | €215,060 | €265,217 | +€50,156 | +23.3% |
| Current portion of amounts payable after more than one year | 42 | €20,967 | €35,842 | +€14,875 | +70.9% |
| Financial debts | 43 | €17,300 | €0 | -€17,300 | -100% |
| Credit institutions | 430/8 | €17,300 | €0 | -€17,300 | -100% |
| Trade debts | 44 | €85,248 | €151,028 | +€65,780 | +77.2% |
| Suppliers | 440/4 | €85,248 | €151,028 | +€65,780 | +77.2% |
| Taxes, remuneration and social security | 45 | €1,026 | €5,473 | +€4,447 | +434% |
| Taxes | 450/3 | €0 | €81 | +€81 | |
| Remuneration and social security | 454/9 | €1,026 | €5,392 | +€4,366 | +426% |
| Other amounts payable | 47/48 | €90,519 | €72,874 | -€17,645 | -19.5% |
| Accrued charges and deferred income | 492/3 | €0 | €208 | +€208 | |
| Remuneration, social security and pensions | 62 | €7,498 | €38,142 | +€30,644 | +409% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €30,749 | €30,403 | -€345 | -1.1% |
| Other operating charges | 640/8 | €2,118 | €2,201 | +€83 | +3.9% |
| Gross operating margin | 9900 | €108,710 | €49,809 | -€58,901 | -54.2% |
| Operating profit (loss) | 9901 | €68,346 | -€20,937 | -€89,283 | |
| Financial income | 75/76B | €2,135 | €1,593 | -€543 | -25.4% |
| Recurring financial income | 75 | €2,135 | €1,593 | -€543 | -25.4% |
| Financial charges | 65/66B | €7,513 | €6,922 | -€591 | -7.9% |
| Recurring financial charges | 65 | €7,513 | €6,922 | -€591 | -7.9% |
| Profit (loss) for the period before taxes | 9903 | €62,968 | -€26,266 | -€89,234 | |
| Income taxes | 67/77 | €2,855 | €0 | -€2,855 | -100% |
| Profit (loss) for the period | 9904 | €60,112 | -€26,266 | -€86,378 | |
| Profit (loss) for the period to be appropriated | 9905 | €60,112 | -€26,266 | -€86,378 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.